128 related articles for article (PubMed ID: 19960725)
1. [Alzheimer dementia. Memantine: value for patient and caregivers].
MMW Fortschr Med; 2009 Nov; 151(45):44-5. PubMed ID: 19960725
[No Abstract] [Full Text] [Related]
2. [Memantine for treatment of behavioural disturbances and psychotic symptoms in moderate to moderately severe Alzheimer dementia: a naturalistic study in outpatient services in Austria].
Schmidt R; Baumhackl U; Berek K; Brücke T; Kapeller P; Lechner A; Rainer M; Stögerer EM
Neuropsychiatr; 2010; 24(2):125-31. PubMed ID: 20605008
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
Bullock R
Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological treatment in severe dementia].
Jouanny P; Belliard S; Bentué-Ferrer D; Michel O; Allain H
Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S51-5. PubMed ID: 15899605
[TBL] [Abstract][Full Text] [Related]
5. Memantine for Alzheimer's disease.
Med Lett Drugs Ther; 2003 Sep; 45(1165):73-4. PubMed ID: 12968123
[No Abstract] [Full Text] [Related]
6. Use of memantine to treat Alzheimer's disease.
Gauthier S; Herrmann N; Ferreri F; Agbokou C
CMAJ; 2006 Aug; 175(5):501-2. PubMed ID: 16940271
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness of memantine for moderate to severe Alzheimer's disease in Sweden.
Jönsson L
Am J Geriatr Pharmacother; 2005 Jun; 3(2):77-86. PubMed ID: 16129384
[TBL] [Abstract][Full Text] [Related]
8. Observations from a 14-week open-label trial with memantine suggest variable response on behavioral symptoms and cognition, depending on former treatment of AD.
Dautzenberg PL; Wouters CJ; Bootsma JE
Int Psychogeriatr; 2006 Mar; 18(1):179-81. PubMed ID: 16734932
[No Abstract] [Full Text] [Related]
9. I remember.
Ladouceur R
Can Fam Physician; 2006 Feb; 52():155. PubMed ID: 16529383
[No Abstract] [Full Text] [Related]
10. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
11. The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis.
Livingston G; Katona C
Int J Geriatr Psychiatry; 2004 Oct; 19(10):919-25. PubMed ID: 15449303
[TBL] [Abstract][Full Text] [Related]
12. [Anti-dementia therapy pays at every stage of the disease. Patients with Alzheimer's disease stay all-day fit longer].
MMW Fortschr Med; 2003 May; 145 Suppl 2():113. PubMed ID: 14579507
[No Abstract] [Full Text] [Related]
13. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.
Feldman HH; Schmitt FA; Olin JT;
Alzheimer Dis Assoc Disord; 2006; 20(4):263-8. PubMed ID: 17132971
[TBL] [Abstract][Full Text] [Related]
14. A review of the effects of memantine on clinical progression in Alzheimer's disease.
Wilkinson D
Int J Geriatr Psychiatry; 2012 Aug; 27(8):769-76. PubMed ID: 21964871
[TBL] [Abstract][Full Text] [Related]
15. Memantine: the next trend in academic performance enhancement?
Ota KS; Godwin T
J Am Osteopath Assoc; 2006 Jun; 106(6):358-9. PubMed ID: 16790543
[No Abstract] [Full Text] [Related]
16. Managing discontinuation syndrome in patients with dementia.
Gauthier S
J Psychiatry Neurosci; 2006 Jan; 31(1):72. PubMed ID: 16496036
[No Abstract] [Full Text] [Related]
17. [Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].
MMW Fortschr Med; 2003 Jun; 145(23):60. PubMed ID: 12854234
[No Abstract] [Full Text] [Related]
18. A 6-month, open-label study of memantine in patients with frontotemporal dementia.
Diehl-Schmid J; Förstl H; Perneczky R; Pohl C; Kurz A
Int J Geriatr Psychiatry; 2008 Jul; 23(7):754-9. PubMed ID: 18213609
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the impact of memantine treatment initiation on psychotropics use: a study from the French national health care database.
Vidal JS; Lacombe JM; Dartigues JF; Pasquier F; Robert P; Tzourio C; Alpérovitch A
Neuroepidemiology; 2008; 31(3):193-200. PubMed ID: 18815451
[TBL] [Abstract][Full Text] [Related]
20. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
[No Abstract] [Full Text] [Related]
[Next] [New Search]
